ArticleBMC medical research methodology2026
Is there a limit to limitations? A proposal for structured limitations reporting in scientific manuscripts.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reporting studies limitations is essential for transparent interpretation. While reporting guidelines such as CONSORT, STROBE, PRISMA mandate disclosure of limitations, no widely adopted framework standardizes how these are reported in a structured and comparable format. In practice, limitations sections often extend over several paragraphs reiterating predictable design-related constraints. This limits comparability, contributes to inefficiency and may overshadow genuine study-specific considerations. We propose a semi-structured checklist combining standardized limitation domains with a concise narrative component. This approach aims to ensure minimum systematic disclosure while preserving critical interpretation. Structured reporting may improve clarity, comparability, and enable meta-research on limitations across studies. Consensus-based refinement and pilot implementation are warranted to evaluate feasibility and impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.